Search the Newsreel

PepGen Inc (PEPG) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for PepGen Inc (PEPG), detailing analyst ratings, price targets, and EPS estimates. Based on 8 analysts, the stock has a "Buy" trend with a target price of $9.00, representing a significant upside. The article also includes recent and …

PepGen Inc. (PEPG) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of August 8, 2025 Deadline

Levi & Korsinsky LLP has announced a class action lawsuit against PepGen Inc. (PEPG), reminding investors of the August 8, 2025 deadline to join. The lawsuit alleges that PepGen made false and misleading statements regarding the efficacy and safety of its lead product candidate, …

PepGen (NASDAQ:PEPG) Posts Earnings Results, Beats Estimates By $0.02 EPS

Is PepGen (NASDAQ:PEPG) In A Good Position To Invest In Growth?

PepGen (NASDAQ:PEPG) has seen its share price increase by 166% over the last year, despite not yet generating revenue. The company had a cash runway of approximately 20 months as of June 2026, with a cash burn of US$69m and US$117m in cash. While …

PepGen Inc. Stock 12‑Month Price Target Cut to $10.19, Implies 323% Upside

Analysts have revised PepGen Inc.'s average 12-month price target down slightly from $10.25 to $10.19, implying a significant 323% potential upside from its Aug. 6 closing price. The consensus rating remains a "Buy" from 8 covering analysts, with the highest target at $20 and …

PepGen - Cash of $117.20 Mln as of June 30, 2

This article provides a brief update on PepGen's financial position, stating that the company had cash reserves of $117.20 million as of June 30, 202X. The content is very minimal, focusing solely on this specific financial figure.

PepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review

PepGen Inc. announced that its independent Data and Safety Monitoring Board (DSMB) has recommended advancing the Phase 2 FREEDOM2-DM1 study of PGN-EDODM1 into its highest multiple ascending dose cohort of 12.5 mg/kg, without changes to the study protocol. The DSMB also advised dose escalation …

PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

PepGen Inc. reported its second quarter 2026 financial results and recent corporate highlights, announcing that its PGN-EDODM1 program for Myotonic Dystrophy Type 1 is advancing. The DSMB recommended escalating PGN-EDODM1 into the highest dose cohort in the FREEDOM2-DM1 study and increasing the dose in …

PepGen Q2 2026 earnings: Lower R&D spending narrows the net loss

PepGen (Nasdaq: PEPG) reported a narrowed net loss of $17.8 million for Q2 2026, down from $23.1 million in Q2 2025, primarily due to a significant reduction in R&D expenses. The company ended the quarter with $117.2 million in cash and expects these funds …

PepGen Inc. 1H 2026: Net loss $(35.6M), EPS $(0.51) — 10-Q Summary

PepGen Inc. reported a consolidated net loss of $(35.6M) and diluted EPS of $(0.51) for the first half of 2026, an improvement compared to the previous year. The company holds $117.2M in cash and marketable securities, which management states will support operations into Q4 …

PepGen advances DM1 trial to highest dose cohort By Investing.com

PepGen Inc. announced that its Phase 2 FREEDOM2-DM1 study of PGN-EDODM1 for myotonic dystrophy type 1 will advance to the highest dose cohort of 12.5 mg/kg, following a positive safety review. The independent Data and Safety Monitoring Board found no serious adverse events or …

Class Action Filed Against PepGen Inc. (PEPG) Over Securities Violations - Contact Levi & Korsinsky Today

A class action lawsuit has been filed against PepGen Inc. (NASDAQ: PEPG) alleging securities fraud between March 7, 2024, and March 3, 2025. The lawsuit claims that PepGen made false statements about the effectiveness and safety of its lead product candidate, PGN-EDO51, and that …

Levi & Korsinsky Urges PepGen Inc. (PEPG) Shareholders to Act Before Lead Plaintiff Deadline August 8, 2025

Levi & Korsinsky is urging shareholders of PepGen Inc. (NASDAQ: PEPG) who suffered losses on their investment between March 7, 2024, and March 3, 2025, to act before the lead plaintiff deadline of August 8, 2025. A class action securities lawsuit alleges that PepGen …

PepGen Inc expected to post a loss of 29 cents a share - Earnings Preview

PepGen Inc is projected to report a loss of 29 cents per share. This information is provided as an earnings preview by Reuters, accessible via TradingView News.

PepGen Inc. Revenue Breakdown – NASDAQ:PEPG

This article provides a brief overview of PepGen Inc.'s revenue breakdown as listed on NASDAQ under the ticker PEPG. It highlights where to find financial information, including segments and regional performance data, through the TradingView platform. The content primarily focuses on navigation within TradingView …

PepGen (PEPG) to Post Quarterly Earnings on Thursday

PepGen Inc (PEPG) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of PepGen Inc (PEPG), detailing its support, resistance, indicators, and moving averages. It summarizes various technical indicators such as MACD, RSI, and CCI, along with moving averages (MA5 to MA200), to offer a comprehensive overview of the stock's …

PepGen Inc (PEPG) Cash Flow

This article provides a detailed cash flow statement for PepGen Inc (PEPG), covering quarterly data from FY2020Q3 to FY2026Q1. It breaks down operating, investing, and financing cash flows, along with changes in working capital and overall cash balances. The document also includes an FAQ …

Recover Investment Losses: Levi & Korsinsky Files Class Action Against PepGen Inc. (PEPG)

Levi & Korsinsky LLP has filed a class action securities lawsuit against PepGen Inc. (NASDAQ: PEPG) on behalf of investors who suffered losses due to alleged securities fraud between March 7, 2024, and March 3, 2025. The lawsuit claims that PepGen made false and …

PepGen Inc (PEPG) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for PepGen Inc (PEPG), detailing its volatility, financial risk, and investment risk. It includes key metrics such as Beta, VaR, Maximum Drawdown, Realized Volatility, and daily return percentages over various periods. The report also covers aspects like Sharpe …

PepGen Inc (PEPG) Shareholder Structure: Major Shareholders & Institutional Holdings

The article provides a detailed breakdown of PepGen Inc's (PEPG) shareholder structure, listing major shareholders and their proportions, as well as categorizing shareholder types. It also presents institutional shareholding data over several quarters and highlights recent shareholder activity, including changes in holdings.